Home

FREDERIC H MOLL

CIK 1260157 · Executive Chairman · last filed 2026-06-10

FREDERIC H MOLL is an Executive Chairman who has filed 94 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for PRCT, was dated Jun 10, 2026. Across all open-market trades the lifetime net is −$4.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $52.3M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$52.28M

Companies

7

Total Filings

94

Lifetime Open-Market Net

-$4.74M

Filer Profile

Reported Address
4000 E DENNY BLAINE PLACE
SEATTLE, WA 98112
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PRCT Director 866,474 $19.30 $16.72M $7.72M 9 2026-06-10
SSII Director 10,775,485 $3.30 $35.56M $2.00M 1 2026-03-10
Shockwave Medical, Inc. (SWAV) Delisted Director 33,960 $334.75 $11.37M -$15.92M 11 2024-05-31
Intersect ENT, Inc. (XENT) Delisted Director 260,961 $28.24 $7.37M -$947.9K 23 2021-02-05
Venus Concept Inc. (HAIR) Delisted Director 13,825 — — $500.0K 5 2019-11-07
BIOLASE, INC (BIOL) Delisted Director 20 $0.02 $0 $0 9 2017-07-03
HANSEN MEDICAL INC (HNSN) Delisted Executive Chairman 279,008 — — $1.91M 14 2012-03-05

Recent Filings

94 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-10 PRCT Grant (A) +3,315 $0 EDGAR
2026-03-10 SSII Buy (P) +501,253 $2.00M EDGAR
2025-08-14 PRCT Buy (P) +20,000 $785.1K EDGAR
2025-06-12 PRCT Grant (A) +1,538 $0 EDGAR
2025-02-24 — Buy (P) +3,645,224 $5.00M
2025-02-12 PRCT Exer (M) +32,012 $40.1K EDGAR
2025-01-10 — Buy (P) +1,457,726 $2.00M
2025-01-03 — Buy (P) +2,186,589 $3.00M
2024-11-27 — Buy (P) +3,644,315 $5.00M
2024-06-06 PRCT Grant (A) +1,376 $0 EDGAR
Showing 1–10 of 94
Page 1 of 10
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.